|
Volumn 7, Issue 13, 2015, Pages 5683-5690
|
Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOCOMPATIBILITY;
CARDIOVASCULAR SYSTEM;
CHEMOTHERAPY;
CONTROLLED DRUG DELIVERY;
DIAGNOSIS;
DISEASES;
ENZYME INHIBITION;
NANOPARTICLES;
TUMORS;
ACIDIC ENVIRONMENT;
DOXORUBICIN NANOPARTICLES;
DRUG LOADING CAPACITY;
FLUORESCENCE PROPERTIES;
IMAGING CAPABILITIES;
MULTIFUNCTIONAL SYSTEMS;
SYSTEMIC TOXICITIES;
THERAPEUTIC EFFICACY;
TARGETED DRUG DELIVERY;
ANTINEOPLASTIC ANTIBIOTIC;
DELAYED RELEASE FORMULATION;
DOXORUBICIN;
NANOCAPSULE;
ADMINISTRATION AND DOSAGE;
ANIMAL;
ANTIBODY SPECIFICITY;
BAGG ALBINO MOUSE;
CELL SURVIVAL;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
DIFFUSION;
DRUG EFFECTS;
DRUG FORMULATION;
DRUG POTENTIATION;
DRUG RESISTANCE;
MATERIALS TESTING;
METABOLIC CLEARANCE RATE;
METABOLISM;
MOUSE;
NEOPLASMS, EXPERIMENTAL;
PARTICLE SIZE;
PATHOLOGY;
PHARMACOKINETICS;
PROCEDURES;
THERANOSTIC NANOMEDICINE;
TISSUE DISTRIBUTION;
TREATMENT OUTCOME;
ULTRASTRUCTURE;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
CELL SURVIVAL;
DELAYED-ACTION PREPARATIONS;
DIFFUSION;
DOXORUBICIN;
DRUG COMPOUNDING;
DRUG RESISTANCE, NEOPLASM;
DRUG SYNERGISM;
MATERIALS TESTING;
METABOLIC CLEARANCE RATE;
MICE;
MICE, INBRED BALB C;
NANOCAPSULES;
NEOPLASMS, EXPERIMENTAL;
ORGAN SPECIFICITY;
PARTICLE SIZE;
THERANOSTIC NANOMEDICINE;
TISSUE DISTRIBUTION;
TREATMENT OUTCOME;
|
EID: 84925308562
PISSN: 20403364
EISSN: 20403372
Source Type: Journal
DOI: 10.1039/c5nr00290g Document Type: Article |
Times cited : (93)
|
References (45)
|